News - Zytiga, Jevtana

Filter

Current filters:

ZytigaJevtana

Popular Filters

Zytiga overtaking Provenge in MCRPC

17-01-2012

Despite no current approval of Johnson & Johnson (NYSE: JNJ) subsidiary Janssen’s Zytiga (abiraterone)…

BiotechnologyDendreonJanssenJevtanaJohnson & JohnsonMarkets & MarketingNorth AmericaOncologyPharmaceuticalProvengeSanofiZytiga

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top